mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-18 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-14 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-13 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-13 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-13 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
4e-13 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-13 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-13 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
9e-12 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |